Inner Balance vs Wisp: Cost, Age Limits, and What Each One Actually Gives You

The HRT Index Editorial TeamIndependent women's health research

Last reviewed:August 10, 2026

Editorial research — not medically reviewed by a clinician. Why this label

Last updated: August 10, 2026 · Last verified: August 10, 2026 · By The HRT Index Editorial Team. Educational research, not medical advice, and not reviewed by a clinician. See our medical review policy. Full disclosure.

Want to match your situation before choosing?

This comparison found Wisp to be the better starting point for most readers, while Inner Balance may fit a narrower need for one compounded vaginal cream. Use the free matching tool if age, symptoms, uterus status, risk history, insurance, or state changes the decision.

Find My HRT Path

The short answer on Inner Balance vs Wisp

For most women comparing Inner Balance vs Wisp, Wisp is the better starting point. Its menopause consult costs $99, medication is paid separately at a local pharmacy, and its listed options are FDA-approved estradiol and progesterone products. Inner Balance costs $597 for the first 90 days and fits a narrower reader who specifically wants one compounded vaginal estradiol-progesterone cream.

Now the conditions that can change that answer completely.

If you are 60 or older, Inner Balance is not an option. Its own website says its cutoff to start is age 59, including women already taking HRT.
If you specifically want estradiol and progesterone together in one vaginal cream, Wisp does not list that option. Oestra fills a real dosage-form gap, but it is compounded and is not an FDA-approved finished product.
If price is the deciding factor, the gap is large. Inner Balance’s first 90 days cost $597. Wisp’s consult costs $99, leaving $498 for pharmacy spending before the totals meet.

Best for / not for you

Wisp is probably your fit if: you want an FDA-approved patch, gel, or pill; you want to use eligible prescription insurance or a discount card at a retail pharmacy; you are 60 or older; or you want to separate the consult decision from the medication purchase.

Inner Balance may fit if: you are 59 or younger; you specifically want estradiol and progesterone in one vaginal cream; you understand that Oestra is compounded; and you prefer one bundled subscription rather than a separate retail-pharmacy checkout.

Neither is your online starting point if: you have new or unexplained bleeding after menopause, need an in-person examination first, or have a history that requires evaluation beyond an asynchronous checkout flow.

What we earn here: nothing. We make no commission from Inner Balance or Wisp. Both provider links on this page are unpaid. We may earn a commission from other providers on The HRT Index, and those links are labeled where they appear.

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Inner Balance vs Wisp at a glance

Decision point	Inner Balance — Oestra	Wisp — menopause consult	Evidence status
What you are buying	A bundled subscription built around one compounded vaginal estradiol-progesterone cream	A $99 menopause consult that may result in prescriptions sent to a local pharmacy	Verified
Published entry price	$199/month for the first six months; $99.50/month after that. The product page also headlines “From $99.50/mo”	$99 one time for the published consult	Verified
Medication included?	Yes, the Oestra prescription is included; additional prescriptions may cost extra	No. Medication is paid for separately at the pharmacy	Verified
First 90 days	$597	$99 + pharmacy cost	Verified + arithmetic
First-year total	$1,791 at the published base subscription rates	Not calculable from public information because month-four care/refill requirements are not published	Verified + arithmetic / not disclosed
Medication status	Compounded prescription; not an FDA-approved finished product	Wisp lists FDA-approved estradiol and progesterone options; exact product, manufacturer, dose, and coverage depend on the prescription	Verified / provider-stated
Routes listed	Daily vaginal cream marketed for systemic use	Estradiol patch, gel, or oral options; micronized progesterone, Provera, and other oral options	Provider-stated
Upper age limit	59 to start, including women already on HRT	No published upper cutoff found; Wisp says later initiation requires a more careful clinical conversation	Verified
Insurance	Inner Balance does not bill insurance and its terms say patients agree not to submit claims	Wisp does not bill insurance for the $99 consult; eligible prescription coverage may be used at the pharmacy	Provider-stated
HSA/FSA	Accepted, but two live Inner Balance pages directly conflict on refund eligibility	Accepted	Verified
Labs required to start	No; optional labs are offered	Not stated on the menopause-consult product page	Verified / not disclosed
Refund policy	Six-month guarantee with two deadlines and other conditions	Terms say sales are final except for narrow circumstances or company discretion	Verified
BBB profile	Not accredited; B−; 12 complaints in the current three-year profile	Not accredited; D−; stated reason is failure to respond to 14 complaints	Verified August 10, 2026
State access	Inner Balance pages publish conflicting counts; confirm during intake	Wisp’s menopause page says “Available in all 50 states”; individual clinical eligibility still depends on intake	Verified / provider-stated

How to read the evidence column:

Verified means we read the claim at its original source and dated the check.
Provider-stated means the company publishes the claim; we did not personally use the service to test it.
Arithmetic means we performed the calculation from named, published inputs.
Not disclosed means the provider’s public pages did not answer the question on the verification date.
Conflict means two current pages from the same provider say different things. We show both and pick neither.

Sources for the comparison table: Inner Balance Oestra treatment page, Inner Balance refund policy, Inner Balance HSA/FSA page, Wisp menopause consult, Wisp Terms of Service, and the current Inner Balance and Wisp BBB profiles. Commercial facts checked August 10, 2026.

What is the real difference between Inner Balance and Wisp?

Inner Balance bundles a compounded medication, clinician review, pharmacy processing, shipping, and ongoing support into one subscription. Wisp sells a consult and follow-up access; if a provider prescribes treatment, the prescription goes to a local pharmacy and medication costs are separate. Comparing $199 with $99 as though they buy the same thing gives you the wrong answer.

Here is the cleanest way to understand the split.

Inner Balance is selling a bundled Oestra pathway

Oestra is the relevant Inner Balance product in this comparison. It combines estradiol and micronized progesterone in one vaginal cream. Inner Balance’s current treatment page says it is used daily, shipped as a three-month supply, and billed monthly. The membership includes treatment, pharmacy processing, shipping, and unlimited clinical support.

That does not mean no pharmacy is involved. Oestra is a prescription compounded by a pharmacy. It means you do not have a second retail-pharmacy checkout after the clinician’s review.

The published base price includes the prescribed Oestra product. Inner Balance’s terms also say additional prescriptions can create additional charges, so “all included” should not be read as a promise that no circumstance can ever produce another bill.

Wisp is selling access to a prescription decision

Wisp’s menopause-consult page says the $99 includes the consult, follow-ups, and three months of Care Team access. If prescribed, medication is sent to a local pharmacy and paid for there.

That gives you more separation and more visibility: you can see the exact prescription and the pharmacy price before paying for the medication. It also gives you more moving parts. A same-day prescription transmission is not a same-day pickup guarantee; pharmacy stock, prior authorization, hours, and price are outside Wisp’s direct control.

Compounded and FDA-approved are different lanes

Compounded means a pharmacy prepares a medication under a compounding pathway. Compounded drugs can meet a legitimate patient need, but the finished product is not FDA-approved. The FDA does not verify a compounded product’s safety, effectiveness, or quality before it is marketed.

FDA-approved means the finished product has gone through FDA review for a specific formulation and has approved prescribing information. The exact dose, route, manufacturer, indication, warnings, and evidence belong to that product—not merely to the hormone name.

Oestra is compounded. Wisp lists FDA-approved options filled by retail pharmacies. That does not make every Wisp prescription automatically right for every woman, and it does not make compounding illegitimate. It means the evidence package and regulatory pathway are different.

One confusion worth killing now: bioidentical does not mean compounded. Estradiol and micronized progesterone are available in FDA-approved products. Wanting a hormone with the same chemical structure as the body’s hormone does not force you into a compounded product.

Still deciding which lane fits? Use Find My HRT Path to sort by age, uterus status, route preference, risk history, insurance, and state before you pay for a consult.

Sources for this section: Inner Balance Oestra treatment page, Inner Balance terms, Wisp menopause consult, and the FDA’s compounding questions and answers. Checked August 10, 2026.

Can you actually use Inner Balance or Wisp?

Inner Balance publishes a hard cutoff: it will not start a woman after age 59, even if she has used HRT for years. Wisp publishes no upper age ceiling and says its menopause consult is available in all 50 states, but treatment still depends on clinical screening. Inner Balance’s published state counts conflict, so its state eligibility must be confirmed at intake.

This is the section we would want you to read if you only read one.

Inner Balance’s age-59 cutoff is real

In an Inner Balance article by founder Sarah Daccarett, MD, the company states:

“At Inner Balance, our cutoff to start is age 59, even if you have been on HRT for years.”

We checked that page live on August 10, 2026. The cutoff is not stated on the main Oestra treatment page where the price and checkout path appear.

That means a 60-year-old who has never used HRT is excluded. So is a 60-year-old who has used it for years and only wants continuity. The rule is not a universal medical prohibition. It is Inner Balance’s eligibility policy.

There is a real clinical idea underneath the rule: for many healthy women, the benefit-risk profile of systemic menopausal hormone therapy is generally most favorable when treatment begins before age 60 or within 10 years of menopause. But “the conversation becomes more individualized after 60” is not the same statement as “no one may start after 59.”

Inner Balance chose a business gate. Wisp says later initiation calls for a more careful clinical conversation.

Winona, another online provider with compounded cream options, also publishes a treatment age range of 35 to 59. So women 60 and older should not assume every online menopause provider will evaluate them simply because the site has a checkout button.

Wisp’s age language is less clean than it should be

Wisp’s July 2026 HRT guide says women 40 and older—or younger women after surgical menopause—are eligible. The same guide separately includes early menopause before 45 and premature ovarian insufficiency among situations where HRT may be appropriate.

Those statements are not identical. We are not converting them into a hard lower-age rule that Wisp’s product page does not publish. If you are under 40, confirm service eligibility during intake instead of relying on one sentence from an educational article.

Wisp does not publish a hard upper cutoff. Its guide says starting after 60 is not automatically off the table, but requires a more careful discussion of the individual benefit-risk picture.

The state-access ledger

Access question	Inner Balance	Wisp
Upper age to start	59, including existing HRT users	No published upper ceiling found
Lower age	Main Oestra page says Inner Balance works with women as young as 21; clinical eligibility still applies	Public guide uses inconsistent under-40 language; confirm in intake
State claim	Current company pages publish different totals	Menopause-consult page says all 50 states
What you should do	Complete the state-and-age check before entering payment details	Confirm that the menopause consult—not merely another Wisp product—is available for your situation and state

If you are 60 or older, this page has bad news and good news.
The bad news: Inner Balance will not start you, and Winona also caps its published treatment range at 59.
The good news: that is a provider rule, not a verdict on whether HRT can ever be considered for you. Compare online menopause providers without assuming an age ceiling or use Find My HRT Path to identify the next evaluation route.

Sources for this section: Inner Balance’s age-cutoff article, Wisp’s menopause consult, Wisp’s July 2026 HRT guide, and Winona’s FAQ. Checked August 10, 2026.

How much do Inner Balance and Wisp really cost?

Inner Balance’s published base rates total $597 for the first 90 days, $1,194 for the first six months, and $1,791 for the first year. Wisp costs $99 for the consult plus the pharmacy price of any prescription. The exact Wisp first-year total cannot be verified because its public pages do not say what continued care or refill authorization costs after month three.

What Inner Balance’s $199 covers

Inner Balance publishes this base schedule:

Months 1–6: $199 per month
Month 7 onward: $99.50 per month
Shipment: a three-month supply, delivered every three months
Billing: monthly
Included: Oestra treatment, clinician review, pharmacy processing, shipping, and unlimited clinical support

That produces exact base-plan arithmetic:

Period	Calculation	Published-base total
First 90 days	$199 × 3	$597
First six months	$199 × 6	$1,194
First 12 months	($199 × 6) + ($99.50 × 6)	$1,791

The headline on the main treatment page says “From $99.50/mo.” The lower rate begins after the first six months. The price a new customer should use for the opening comparison is $199 per month, not $99.50.

The shipping and billing clocks are different: a 90-day supply arrives, while the card is charged monthly. Inner Balance’s terms also address customers who receive a three-month supply and cancel before all three related monthly payments have been collected. Read the checkout terms as a three-month dispensing cycle billed in installments, not as three unrelated one-month purchases.

What Wisp’s $99 covers

Wisp states that $99 includes:

The menopause consult
Follow-ups
Three months of Care Team access

It does not include the medication. If prescribed, you pay the local pharmacy.

Wisp also publishes a fairer declined-treatment rule than many readers expect: if its provider cannot prescribe any treatment, the company says it may charge up to $25 for the provider review instead of the full consult price.

What current pharmacy prices show—and what they do not

Pharmacy prices depend on the exact drug, strength, quantity, manufacturer, ZIP code, pharmacy, coupon, and insurance formulary. A national coupon page is not your checkout quote.

For a reproducible illustration, we checked GoodRx on August 10, 2026:

GoodRx selection	Displayed cash/coupon price	What the number means
Generic estradiol, GoodRx’s default most-common selection	As low as $37.01	Dynamic national coupon display, not a guaranteed local price
Generic progesterone 100 mg, 30 capsules	$19.55 in GoodRx’s dosage table	Dynamic national coupon display, not a guaranteed local price
Three fills of both selections	$169.68	Our arithmetic: ($37.01 + $19.55) × 3

This is not a quote for your treatment. Your provider may prescribe a different route, strength, quantity, or product. Insurance may lower the cost, deny the product, require prior authorization, or steer you to a preferred pharmacy. A discount card price also cannot be combined with insurance as though they were two discounts on one claim.

What the check does show is scale. At those displayed generic prices, three fills total $169.68—well below the $498 break-even gap.

The $498 question

Inner Balance’s first 90 days cost $597. Wisp’s consult costs $99. That leaves $498 for pharmacy spending before the two totals meet.

That threshold is the original number worth keeping because it does not require us to pretend we know your prescription. You can take your actual pharmacy quote and apply it yourself.

Pharmacy total below $498: the Wisp path costs less for the first 90 days.
Pharmacy total above $498: the Inner Balance base path costs less for the first 90 days.
No prescription after review: Wisp says the charge may be reduced to as much as $25.

The price conclusion is strong, but it has a boundary: these routes are not therapeutically interchangeable. One is a compounded combined vaginal cream. The other may be a patch, gel, or pill plus a separate oral progestogen. Cheaper means cheaper. It does not tell you which formulation is medically appropriate.

The annual Wisp number we will not invent

Wisp publishes three months of Care Team access. It does not publicly explain, on the menopause-consult page, how many refills are normally authorized, whether month-four support requires another consult, or whether another $99 fee is required for continued management.

So there is no defensible single first-year Wisp total from public data. Any annual number would require an assumption that could be wrong.

Use your real number, not ours. Before paying, ask Wisp how many refills the prescription will carry, what happens after three months of Care Team access, and whether another consult fee is required. Then put the pharmacy’s actual 90-day quote next to Inner Balance’s fixed $597 first-cycle total.

Sources for this section: Inner Balance Oestra treatment page, Inner Balance terms, Wisp menopause consult, GoodRx estradiol prices, and GoodRx progesterone prices. Provider and price displays checked August 10, 2026; pharmacy prices vary by product, quantity, pharmacy, and location.

Is Oestra FDA-approved, and why does that matter?

Oestra is a compounded prescription, not an FDA-approved finished product. Wisp lists FDA-approved estradiol and progesterone options dispensed through retail pharmacies. The practical difference is documentation: an approved product has FDA-reviewed labeling for its exact formulation; Oestra’s finished formulation does not. Compounding can still be appropriate when a patient’s needs cannot be met by an approved product.

What compounded really means

Federal law has two commonly discussed compounding pathways:

A 503A pharmacy generally compounds for an identified individual patient under a prescription and is primarily overseen day to day by state boards of pharmacy. Products compounded under 503A are not subject to the same current good manufacturing practice requirements as FDA-approved manufacturers.
A 503B outsourcing facility registers with the FDA, compounds sterile drugs, is subject to current good manufacturing practice requirements, and appears on an FDA list that includes inspection information. Registration still is not product approval.

Neither pathway turns a compounded finished product into an FDA-approved drug.

Inner Balance’s 503A/503B conflict is on one live page

The current Oestra treatment page displays “503A U.S. pharmacy” near the top. Farther down, its FAQ says Oestra is made by a “503B FDA-regulated compounding pharmacy.”

Those classifications are not interchangeable labels for the same legal pathway. We are not picking one and calling the other a typo. The company should answer this before payment:

Which pharmacy will make my prescription, what is its legal name and location, and is the specific facility operating under section 503A or registered with the FDA as a 503B outsourcing facility?

If the answer is 503B, the facility can be checked against the FDA’s current registered-outsourcing-facility list. If the answer is 503A, check the state pharmacy license and any accreditation the company names.

Why a product-specific dose and label matter

Inner Balance says the formula can be adjusted, and its public materials have changed over time. Customization is one reason compounding exists. It also means you cannot infer your exact dose from a general hormone name or from a study of a different route, base, concentration, or schedule.

For an FDA-approved drug, the prescribing information identifies the finished product, strengths, approved indications, warnings, administration instructions, and supporting clinical data. With a compounded product, ask for the prescription label and formulation details directly:

Estradiol amount per measured dose
Progesterone amount per measured dose
Base or vehicle
Number of measured doses in the shipment
Instructions if one hormone needs adjustment but the other does not
Beyond-use date and storage instructions
Pharmacy name and contact information

We did not find product-specific, published pharmacokinetic or endometrial-protection data for Oestra’s exact finished formulation in the sources searched through August 10, 2026. That is not a claim that no internal data exist. It means a reader cannot independently inspect such data from the public record we found.

The honest case for a compounded combined cream

The FDA and major medical organizations do not recommend routine use of compounded menopausal hormone therapy when an FDA-approved product can meet the patient’s needs. They also recognize that compounding may serve a patient who needs a dosage form or ingredient configuration that an approved product does not provide.

That is Oestra’s strongest case. There is an FDA-approved oral estradiol-progesterone combination—Bijuva—but we found no FDA-approved product that combines estradiol and progesterone in one vaginal cream for systemic menopausal hormone therapy.

So the dosage-form gap is real. A woman who specifically needs or prefers that route after a clinician evaluates the trade-offs is not choosing an imaginary category. She is choosing a compounded category because the approved combined vaginal product does not exist.

The boundary matters just as much: evidence from Bijuva, an estradiol patch, oral micronized progesterone, or low-dose local vaginal estrogen does not transfer automatically to Oestra’s compounded combined vaginal formulation.

“Bioidentical” does not close the evidence gap

Estradiol and micronized progesterone can be chemically identical to endogenous hormones and still exist in different regulatory categories. FDA-approved bioidentical products exist. Compounded bioidentical products also exist.

The word describes molecular structure. It does not establish dose accuracy, absorption, effectiveness, endometrial protection, manufacturing quality, or FDA approval for the finished product.

What the FDA’s 2025–2026 label changes did—and did not—change

In November 2025, the FDA initiated changes to boxed-warning language for menopausal hormone therapy. On February 12, 2026, it approved updated labeling for an initial six products: Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva.

Those actions apply to FDA-approved products and their FDA-reviewed labels. They did not approve Oestra, create an FDA-reviewed Oestra label, or convert any compounded preparation into an approved drug.

Oestra is applied vaginally but marketed by Inner Balance for systemic effects. It should not be casually grouped with low-dose local vaginal estrogen, which is designed primarily for genitourinary symptoms and produces much lower systemic exposure.

If a finished product with a public label, identifiable dose, and retail-pharmacy price is the lane you want, see Wisp’s current $99 menopause consult and state availability. (Unpaid link.)

Sources for this section: the FDA’s compounding questions and answers, registered outsourcing-facility information, Bijuva prescribing information, and the FDA’s February 2026 menopausal hormone therapy labeling changes. Checked August 10, 2026.

If you still have a uterus, what protects the uterine lining?

If you have a uterus and use systemic estrogen, adequate progestogen exposure is needed to protect the endometrium. Wisp can prescribe the hormones separately, using FDA-approved products with product-specific labeling. Oestra contains vaginal progesterone in the same compounded cream, but no FDA-reviewed label establishes endometrial protection for Oestra’s exact formulation, dose, and schedule.

This is not a side question. It is the question that can outweigh price.

Systemic estrogen stimulates the endometrium. In a woman with a uterus, using systemic estrogen without adequate progestogen increases the risk of endometrial hyperplasia and cancer. The progestogen dose, route, schedule, and relationship to the estrogen dose matter.

What the vaginal-progesterone evidence actually says

The original draft went too far by treating all vaginal or compounded progesterone evidence as one unresolved block. The evidence is more specific than that.

The British Menopause Society’s May 2026 guideline says studied vaginal micronized progesterone schedules of 200 mg for 12 days per month or 100 mg daily provided endometrial protection for up to three years with low- or medium-dose estrogen. It also says evidence is insufficient for other schedules and for use beyond three years. A separate trial using 45 mg for 10 days per month with low-dose estradiol reported more endometrial hyperplasia than placebo.

That is the lesson: route alone does not answer the protection question. The exact dose and schedule do.

Oestra’s public page does not provide an FDA-reviewed endometrial-protection claim for its exact combined formulation. It also combines the hormones, which may limit the ability to adjust progesterone independently from estradiol. That does not prove the formula fails. It means the provider should explain the basis for the prescribed regimen and the monitoring plan.

What each path gives you to work with

Uterus-protection question	Inner Balance — Oestra	Wisp — separate prescriptions
Progestogen included?	Yes, progesterone is in the compounded cream	If clinically indicated, a separate progestogen can be prescribed
Route	Vaginal, in the same formulation as estradiol	Wisp lists oral micronized progesterone, Provera, and other oral options
FDA-reviewed label for the exact regimen?	No	Yes for the exact FDA-approved products, when used as labeled
Can estrogen and progestogen be adjusted independently?	Not clear from the public treatment page; confirm before payment	Yes, because they are separate prescriptions
Published monitoring protocol	Labs not required to start; exact endometrial-monitoring protocol is not published	Determined by the treating clinician; product page does not publish a universal protocol

Your message before paying, word for word:

I have a uterus. What specifically protects my uterine lining with this exact regimen, what evidence supports this dose and schedule, and what bleeding or monitoring plan will you use?

A direct answer should name the formulation, dose, schedule, and follow-up—not merely say that progesterone is present.

If you are bleeding after menopause, stop here

This is the one part of the page where we are not routing you to a checkout page.

Postmenopausal bleeding means bleeding after 12 months without a menstrual period. The American College of Obstetricians and Gynecologists’ April 2026 guidance says most patients with postmenopausal bleeding should receive both transvaginal ultrasound and endometrial tissue sampling in the initial evaluation, with limited exceptions for selected lower-risk situations.

Most postmenopausal bleeding is not endometrial cancer. But bleeding is the presenting sign in more than 90% of women with endometrial carcinoma, which is why the symptom gets evaluated instead of normalized online.

Inner Balance’s own age-stage article says intermittent bleeding or spotting can occur for three to six months after starting and that significant cramping can occur. That may describe a treatment effect. It does not remove the need to report and evaluate postmenopausal bleeding.

A portal message can start the conversation. It cannot perform the ultrasound or obtain a tissue sample.

If you are bleeding after menopause, get evaluated. Everything else on this page can wait.

Medical sources for this section: The Menopause Society’s hormone-therapy guidance, the British Menopause Society’s May 2026 guideline, and ACOG’s April 2026 postmenopausal-bleeding guidance.

What happens to your money if the treatment is not a fit?

Inner Balance advertises a six-month Oestra guarantee, but a refund is not automatic: the request must be made through secure chat within six months of the original order and within 14 days of cancellation. Wisp advertises no comparable guarantee; its terms say sales are final except for four narrow situations or company discretion.

Inner Balance’s guarantee has two clocks

The marketing says six months. The refund policy adds the operational rules:

Submit the request through secure chat in your Inner Balance account.
Submit it within six months of the original order date.
Submit it within 14 days of cancellation.
Cancellation by itself does not start a refund.
Refund eligibility is limited to one refund per customer.
The refund can cover up to six months of Oestra subscription fees.
The subscription must be self-pay rather than reimbursed by private insurance, Medicare, or Medicaid.
Supplements, lab tests, third-party services, Libida, and NAD+ are excluded.

Those are not reasons to dismiss the guarantee. They are the steps required to use it.

The most practical move is to calculate both deadlines on the day you order and save the refund-policy page. “Six months” is not enough information if the separate 14-day post-cancellation clock is missed.

The HSA/FSA contradiction is direct

Inner Balance’s live refund policy says:

“Purchases made with HSA/FSA cards are eligible for a refund.”

Its live HSA/FSA page says:

“HSA/FSA purchases are non-refundable. They are also not valid under the six-month money-back guarantee.”

Both pages were live on August 10, 2026. They cannot both govern the same purchase in the same way.

If the guarantee is part of why you feel safe trying Oestra, do not use an HSA or FSA card until Inner Balance confirms the applicable rule in writing. Save the answer with the checkout confirmation.

What cancel anytime means when a 90-day supply is billed monthly

Inner Balance says Oestra is delivered every three months and billed monthly. Its terms say that if you receive three months of Oestra and cancel before payment has been collected for all three months, you may be charged a reactivation fee later.

That does not explicitly say every remaining installment becomes immediately due. It does show that cancellation does not erase the fact that a three-month prescription was dispensed. Before payment, ask what happens to the remaining monthly charges if you cancel after shipment but before all three payments have been collected.

Wisp’s terms say sales are final

Wisp’s Terms of Service, last updated May 6, 2026, state that sales are final. The terms list four situations in which Wisp may provide a refund or replacement:

A product is out of stock
A prescription product is unavailable at local pharmacies
A product arrives damaged, broken, or defective
A purchased product is not received

Outside those situations, refunds are at Wisp’s discretion. For Wisp subscription products, cancellation must be received at least 48 hours before the next refill or renewal period to avoid the next charge. That subscription rule should not be misread as proof that the one-time $99 menopause consult automatically renews; the current menopause page presents the consult as a one-time price.

The refund ledger

Refund decision	Inner Balance	Wisp
Guarantee advertised	Yes, six months for Oestra	No comparable guarantee
Automatic after cancellation?	No; secure-chat refund request required	No
Main deadlines	Within six months of original order and within 14 days of cancellation	Terms do not publish a broad satisfaction-refund window
HSA/FSA issue	Two current pages directly conflict	HSA/FSA accepted; no special satisfaction guarantee published
Subscription cancellation rule	Cancel through secure portal; three-month dispensing and monthly billing need written clarification	48 hours before renewal for subscription products
Base spending by day 90	$597	$99 consult + pharmacy purchase, if prescribed

Wisp does not give you a money-back guarantee. If a refundable trial period is what lets you say yes, Wisp is the wrong choice and Inner Balance publishes the stronger offer.

But the way the money is separated still matters. With Wisp, the fixed provider charge is $99, and you can see the prescribed medication and pharmacy price before paying the pharmacy. With Inner Balance, the published base path reaches $597 over the first 90 days, and the guarantee has two deadlines plus a live HSA/FSA contradiction.

That is the pivot—not “only $99 is at risk.” Any medication you buy at the pharmacy also costs money and may be nonreturnable. The advantage is that the consult and drug purchase are separate decisions, not that the drug is free or refundable.

If that trade fits you—smaller fixed consult fee, a product label you can inspect, and a pharmacy quote before the medication purchase— check Wisp’s current menopause-consult details and state availability. (Unpaid link.)

Sources for this section: Inner Balance’s refund policy, Inner Balance’s HSA/FSA page, Wisp’s Terms of Service, and the current Inner Balance and Wisp BBB profiles. Checked August 10, 2026.

Are Inner Balance and Wisp legitimate?

Both are real telehealth businesses with prescription workflows and named clinical leadership. Neither is BBB accredited. Inner Balance’s current BBB profile is B− with 12 complaints; Wisp’s is D−, with BBB naming failure to respond to 14 complaints as the reason. Those profiles matter for service risk, but they do not prove that a particular prescription is safe or appropriate for you.

“Is it legit?” is actually several questions hiding inside one sentence.

1. Is the company real?

Yes. Both companies operate public telehealth platforms, publish terms and privacy documents, identify business entities and provider leadership, and route prescription decisions through licensed clinicians.

Both display LegitScript seals. We did not treat a seal as a substitute for checking the medication pathway, pharmacy identity, clinician license, price, and refund terms. A badge answers one trust question. It does not answer all of them.

2. Is the clinician licensed in your state?

Both companies say prescriptions are reviewed by licensed clinicians. The useful check is not whether a site says “licensed.” It is who reviewed your intake.

Ask for the clinician’s full name and license type, then verify the license through your state’s professional-licensing board. That is more specific than any platform-wide badge.

3. Is the pharmacy clear?

Wisp sends a prescription to a retail pharmacy you choose or already use. The pharmacy name is visible before the medication is dispensed.

Inner Balance’s public Oestra page says 503A in one place and 503B in another. Until the exact dispensing pharmacy and facility classification are named, this part of Inner Balance’s legitimacy check remains unresolved—not because compounding is inherently illegitimate, but because the company’s own disclosure conflicts.

4. Is the finished product FDA-approved?

Wisp lists FDA-approved medication options. Confirm the exact product and manufacturer on the pharmacy label.

Oestra is compounded. It is not an FDA-approved finished product. The fact that estradiol or progesterone appears in FDA-approved products does not transfer approval to Oestra’s combined compounded formulation.

5. Do the customer-service records agree?

No—and that is normal for large public review pools. The sources measure different populations and different products.

Review source	Inner Balance	Wisp	What it can and cannot tell you
BBB	Not accredited; B−; 12 complaints in the current three-year profile	Not accredited; D−; BBB says the reason is failure to respond to 14 complaints	Useful for complaint handling and business-response patterns; allegations are not clinical findings
Company-displayed rating	4.9/5 from 5,695 reviews on the Inner Balance site	4.3/5 on Wisp’s menopause product page	Selected or displayed by the provider; methodology and product mix may differ
Trustpilot	3.1/5 from 15 reviews; unclaimed profile; no history of inviting reviews	4.0/5 from 11,388 reviews; claimed profile; paid Trustpilot subscription; invites customers to review	Independent platform, but Wisp’s pool covers its full catalog—not menopause care alone

Do not average those numbers into a fake master score. A 15-review unclaimed profile and an 11,388-review company-wide profile are not comparable samples. Neither belongs in schema as The HRT Index’s own rating.

What real customers said about service—not medical outcomes

We included only brief, attributable service comments. These are individual experiences, not proof of effectiveness, safety, or typical results.

“Fast response from doctors.” — Wisp Trustpilot review, marked invited, August 2026

“I was very pleasantly surprised that it wasn't a hassle.” — Inner Balance Trustpilot review describing a refund experience, July 2026

The opposite experiences are present too: Wisp reviews and BBB posts describe delayed support, renewal confusion, and refund frustration; Inner Balance reviews and complaints describe cancellation, billing, and the separate 14-day refund-request clock. That is why the policy text matters more than selecting the testimonial that matches what you hope will happen.

What we did with provider outcome percentages

Inner Balance publishes large symptom-improvement percentages and labels at least some of them as internal data. We did not use those figures to prove efficacy. The public pages do not provide enough study detail to treat them as independent clinical evidence for Oestra’s finished formulation.

Wisp’s large Trustpilot pool also does not prove menopause-treatment outcomes. It includes reviews about many services, including infections, contraception, testing, and other products.

Service reviews can help you judge speed, communication, billing, and cancellation friction. They cannot tell you whether a hormone regimen is medically right for your body.

Verify the parts that can be verified. Check the clinician’s state license, confirm the dispensing pharmacy, read the exact prescription label, and save the refund terms. Trust is stronger when it does not depend on taking either company’s homepage at face value.

Sources for this section: the current Inner Balance BBB profile, Wisp BBB profile, Inner Balance Trustpilot profile, and Wisp Trustpilot profile. Ratings and counts checked August 10, 2026; review platforms reflect different customer pools and are not evidence of medical efficacy.

Which is better for your situation: Inner Balance or Wisp?

Wisp wins for most readers because it offers route choice, separate prescriptions, a lower fixed consult cost, retail-pharmacy visibility, and no published upper age ceiling. Inner Balance wins one narrower decision: a woman 59 or younger who knowingly wants estradiol and progesterone in one compounded vaginal cream and accepts the documentation and refund trade-offs.

If this is your situation	Better starting point	What is not equivalent
You are 60 or older	Wisp or another provider willing to evaluate later initiation; not Inner Balance	Being over 59 does not create a universal HRT prohibition. It triggers a more individualized benefit-risk discussion
You are under 40	Confirm eligibility before payment; Wisp’s public age statements conflict, while Inner Balance says it works with women as young as 21	A platform’s marketing age is not a diagnosis or proof that systemic HRT is appropriate
You have a uterus and want systemic estrogen	Wisp has the clearer documentation lane because estrogen and progestogen can be prescribed separately as FDA-approved products	Progesterone being present in a compounded cream is not the same as product-specific evidence for the exact regimen
You have had a hysterectomy	Wisp may fit better because the clinician can prescribe estrogen without automatically bundling progesterone when it is not indicated	Oestra always combines estradiol and progesterone; ask why both are appropriate for your situation
Your main problem is vaginal dryness or painful sex	Ask about low-dose local vaginal estrogen before assuming you need either systemic pathway	Vaginal placement does not automatically mean local treatment. Inner Balance markets Oestra for systemic absorption
You want a patch or gel	Wisp	Oestra is a cream; it is not a substitute for an FDA-approved transdermal product
You want both hormones in one vaginal cream	Inner Balance	We found no FDA-approved combined estradiol-progesterone vaginal cream
You need insurance to help with medication	Wisp lets you try eligible prescription coverage at the pharmacy; the $99 visit remains cash pay	Prescription coverage is not coverage for the consult
You want a published satisfaction guarantee	Inner Balance	The guarantee has two deadlines and a live HSA/FSA contradiction; Wisp has no comparable guarantee
You want the lowest fixed amount before seeing a prescription	Wisp	The $99 consult does not include the medication
You want one bundled bill and no retail-pharmacy checkout	Inner Balance	The bundled convenience comes with a higher first-cycle cost and a compounded product
You have postmenopausal bleeding	Neither online checkout	Get the bleeding evaluated before choosing a program

If Inner Balance is genuinely your fit

Some readers arrive here wanting exactly what Oestra is: one combined vaginal cream, no patch, no separate progesterone capsule, one subscription, home delivery.

If that is you, Inner Balance is the provider in this comparison that offers it. We are not going to pretend Wisp gives you the same dosage form. Go in with your eyes open and get four answers in writing before payment:

The exact pharmacy name and 503A or 503B classification
Your exact estradiol and progesterone amounts per measured dose
The basis for endometrial protection if you have a uterus
Which HSA/FSA refund statement applies to your purchase

See Inner Balance’s current Oestra page and terms. (Unpaid link.)

If Wisp is your fit

Wisp fits the reader who wants a lower fixed consult fee, a patch/gel/pill choice, an identifiable FDA-approved product, independent adjustment of estrogen and progestogen, and a retail pharmacy where insurance or a coupon can be tested.

Before paying, confirm the month-four plan. The first three months are published. The refill and continued-support path after that is not.

See Wisp’s current menopause-consult page. (Unpaid link.)

If neither fits

Neither company bills the visit as comprehensive in-person care. Neither public page answers every state, examination, imaging, or complex-risk question. A woman who needs insurance-billed care, an in-person pelvic examination, continuity after age 59, or management of a more complicated history may need a different provider model.

The HRT Index’s Find My HRT Path tool is built for that fork. It matches the next starting point to age, symptoms, uterus status, route preference, risk history, insurance, and state—and flags when online care is not the right first step.

How did The HRT Index compare Inner Balance and Wisp?

We used current provider pages, checkout and policy documents, FDA and professional-society guidance, retail drug-price pages, and public trust profiles. Where one company contradicted itself, we preserved the conflict instead of choosing the more favorable version. We earn no commission from either provider.

The HRT Index Verification Standard

The HRT Index Verification Standard is the documented process we use to review providers: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule—top providers monthly and the full roster quarterly.

It is not a score. We do not assign invented numeric ratings to providers because a single number hides the exact trade-off the reader needs to see.

We evaluate providers on five pillars, always in this order:

Clinical legitimacy
Care quality
Medication fit
Price transparency
Access

What we actually verified

Provider and policy checks completed August 10, 2026: Inner Balance’s $199/$99.50 schedule; three-month shipment and monthly billing; age-59 cutoff; no-insurance clause; included medication and additional-prescription language; six-month guarantee conditions; HSA/FSA refund conflict; 503A/503B conflict; Wisp’s $99 consult inclusions; listed medication routes; all-50-state claim; up-to-$25 declined-treatment charge; May 6, 2026 Terms of Service; and both current BBB profiles.

Medical and regulatory checks: FDA compounding status and 503A/503B distinctions; The Menopause Society’s distinction between approved and compounded bioidentical products; the British Menopause Society’s 2026 regimen-specific vaginal-progesterone evidence; ACOG’s April 2026 postmenopausal-bleeding guidance; and the FDA’s February 2026 menopausal-hormone-label changes.

Price check: GoodRx’s live estradiol and progesterone displays on August 10, 2026. Those prices are dynamic illustrations, not patient-specific quotes.

What remains undisclosed or conflicted

Inner Balance’s exact current state count
The pharmacy identity and whether the dispensing facility is 503A or 503B
Product-specific published pharmacokinetic and endometrial-protection data for Oestra’s exact formulation
The exact price of any additional Inner Balance prescription or dose-related change that falls outside the base subscription
Whether Wisp routinely requires labs for this specific menopause service
How many refills a typical Wisp menopause prescription authorizes
Whether continued support after three months requires another $99 consult
The exact medication, pharmacy price, insurance coverage, prior authorization, and pickup timing for any individual Wisp patient
Wisp’s clean under-40 eligibility rule, because its current educational guide contains two formulations of the policy

Those are not empty spaces for us to fill with guesses. They are the questions to carry into intake.

What should you confirm before paying Inner Balance or Wisp?

Both providers leave material questions unanswered on their public pages. Copy the list below into the intake or secure portal and keep the responses. A written answer is more useful than remembering what a checkout screen appeared to imply.

#	Question to ask	Why it matters
1	Which pharmacy will make or fill my prescription? Give me its legal name, location, and license information.	Establishes who is dispensing the drug
2	For Inner Balance: is that facility operating under 503A or registered as a 503B outsourcing facility?	Inner Balance’s own page uses both classifications
3	What exact medication, strength, manufacturer, route, and quantity will I receive?	Route names alone do not identify the finished product
4	Can estrogen and progesterone be adjusted independently?	Important if symptoms, bleeding, or side effects require one component to change
5	I have a uterus. What protects my uterine lining with this exact regimen, and what evidence supports it?	The central safety question for systemic estrogen
6	What bleeding should trigger same-day contact, urgent evaluation, ultrasound, or biopsy?	“Spotting can happen” is not a complete monitoring plan
7	Is this specific service available for my age and state before I enter payment details?	Inner Balance has an age ceiling and conflicting state counts
8	Are labs, imaging, or an in-person examination required in my situation, and who pays?	Public pages do not resolve every clinical pathway
9	What will my card be charged today, over the first 90 days, and if treatment is not prescribed?	Separates consult, subscription, and medication costs
10	For Inner Balance: if I pay with HSA/FSA, which refund policy applies?	Two live pages give opposite answers
11	What are my cancellation and refund deadlines as calendar dates?	Inner Balance has two refund clocks; Wisp subscriptions use a 48-hour cutoff
12	For Wisp: how many refills are authorized, what happens after three months, and when would another consult fee apply?	Determines the real first-year cost
13	Who reviewed my intake, and what is the clinician’s license number?	Lets you verify the actual clinician in your state
14	What is the total pharmacy price before I agree to fill the prescription?	The $99 Wisp consult does not include medication

Print this table, save it as a note, or paste it into the portal. No separate download or email gate is needed.

Inner Balance vs Wisp: frequently asked questions

Is Wisp cheaper than Inner Balance?

For the published first 90 days, usually yes. Inner Balance costs $597. Wisp costs $99 plus the pharmacy price, so the pharmacy bill would have to exceed $498 before the Wisp total passes Inner Balance’s base total. GoodRx’s illustrative generic displays were far below that threshold on August 10, 2026, but your actual prescription price controls.

Is Oestra FDA-approved?

No. Oestra is a compounded prescription, not an FDA-approved finished product. The FDA does not verify a compounded finished product’s safety, effectiveness, or quality before marketing. Approval of other estradiol or progesterone products does not transfer to Oestra.

Does Wisp prescribe FDA-approved hormones?

Wisp’s menopause page lists estradiol patch, gel, and oral options plus micronized progesterone, Provera, and other oral options. Those are FDA-approved medication categories, but the exact product, manufacturer, strength, quantity, and indication depend on the prescription. Confirm them on the pharmacy label.

Does Inner Balance have an age limit?

Yes. An Inner Balance article says its cutoff to start is age 59, including women who have already used HRT for years. The main Oestra treatment page does not surface that cutoff alongside the price and checkout path.

Is Wisp available in all 50 states?

Wisp’s menopause-consult page says “Available in all 50 states.” That is the current provider-stated claim. Individual eligibility still depends on age, history, clinician review, state-specific telehealth requirements, and the medication requested.

Is Inner Balance available in all 50 states?

The company’s own pages have published conflicting state totals. We are not choosing one. Confirm the Oestra service for your state during intake before payment.

Can you get a refund from Inner Balance?

Potentially. The request must be sent through secure chat within six months of the original order and within 14 days of cancellation. It is limited to one refund per customer and up to six months of Oestra subscription fees. Cancellation alone does not trigger it.

Does Wisp give refunds?

Wisp does not publish a satisfaction guarantee. Its terms say sales are final, with narrow exceptions involving stock, local-pharmacy availability, damage or defect, and nonreceipt, plus refunds at company discretion.

Can I use HSA or FSA for either provider?

Both say yes. Wisp’s menopause page marks the consult HSA/FSA accepted. Inner Balance accepts HSA/FSA for Oestra, but its refund policy says those purchases are refundable while its HSA/FSA page says they are not. Get the Inner Balance rule in writing before using those funds.

Do either of them take insurance?

Inner Balance does not bill insurance and its terms say patients agree not to submit claims. Wisp’s $99 consult is cash pay. At the local pharmacy, eligible prescription insurance may be applied to the medication, subject to the plan’s formulary, deductible, prior authorization, and pharmacy rules.

Do I need lab tests?

Inner Balance says labs are not required to begin and optional testing is available. Wisp’s menopause-consult product page does not publish a universal lab rule. A clinician may still decide that labs, imaging, records, or an in-person examination are needed for your situation.

What if I still have a uterus?

Ask what protects the endometrium with the exact estrogen dose, progestogen dose, route, and schedule. Wisp can use separate FDA-approved products with product-specific labeling. Oestra combines vaginal progesterone and estradiol, but it has no FDA-reviewed label establishing protection for its exact compounded regimen.

What if I have had a hysterectomy?

Tell the clinician exactly what surgery you had. Estrogen-only treatment is commonly used after the uterus has been removed, while Oestra bundles progesterone with estradiol. That makes the reason for the progesterone a question worth asking rather than accepting automatically.

What if vaginal dryness is my only symptom?

Ask about low-dose local vaginal estrogen before assuming you need systemic therapy. Low-dose local therapy is a different category designed primarily for vaginal and urinary symptoms. Oestra is vaginally applied but marketed by Inner Balance for systemic effects.

What if I am bleeding after menopause?

Do not use a provider comparison as a substitute for evaluation. ACOG’s April 2026 guidance recommends both transvaginal ultrasound and endometrial tissue sampling for the initial evaluation of most patients with postmenopausal bleeding, with selected exceptions. Get evaluated before choosing an online HRT program.

Is “bioidentical” the same as “compounded”?

No. Bioidentical describes molecular structure. Compounded describes how the finished medication was prepared and regulated. FDA-approved bioidentical estradiol and micronized progesterone products exist, so choosing bioidentical hormones does not require a compounded product.

Does Wisp include the medication in the $99 price?

No. The $99 covers the consult, follow-ups, and three months of Care Team access. If prescribed, medication is paid for at the local pharmacy.

Does Inner Balance include medication in the subscription?

The base Oestra prescription, pharmacy processing, shipping, and unlimited clinical support are included in the published subscription. Inner Balance’s terms say additional prescriptions can create additional charges.

The bottom line on Inner Balance vs Wisp

For most women, Wisp is the better place to start. You pay a $99 consult instead of reaching $597 over the first 90 days, you can see the exact FDA-approved prescription and pharmacy price, you can try eligible insurance at the pharmacy, and there is no published age ceiling waiting at the end of the process.

Inner Balance is the honest answer for a narrower reader: 59 or younger, specifically wanting estradiol and progesterone together in one vaginal cream, and knowingly choosing a compounded formulation because no FDA-approved combined vaginal cream fills that exact dosage-form request.

The strongest case against Wisp is real: there is no money-back guarantee. The strongest case against Inner Balance is also real: the first-cycle cost is much higher, the pharmacy classification conflicts on its own page, the age ceiling is buried outside the product page, and its two HSA/FSA refund statements cannot both be right.

Neither company gets to replace your judgment. Get the prescription details, pharmacy identity, uterus-protection answer, state eligibility, and refund dates in writing before your card is charged.

You are not being reckless for wanting help. You are doing what anyone should do before spending real money on her health: checking the path before stepping onto it.

Still not sure which HRT program is right for you? Take our free 60-second matching quiz.

Sources

Provider pricing, access, and policies — checked August 10, 2026

Medical and regulatory

Drug-price illustration — checked August 10, 2026

Business and customer-service records — checked August 10, 2026

Last verified August 2026 · By The HRT Index Editorial Team · Editorial research. Not medically reviewed by a clinician. Educational only — not medical advice.

Still comparing HRT care models?

Review the best online HRT providers, compare HRT costs in 2026, or use the free Find My HRT Path tool.

Keep reading: